Ghrelin produces antidepressant-like effect in the estrogen deficient mice

Jie Fan1, Bing Jin Li1, Xue Feng Wang1

  • 1Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China.

Oncotarget
|September 24, 2017
PubMed

Insights

Ghrelin demonstrates antidepressant-like effects in ovariectomized mice by reducing immobility and increasing brain-derived neurotrophic factor (BDNF). Estrogen receptors appear to mediate these beneficial impacts, suggesting a novel therapeutic avenue.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pharmacology

Background:

  • Ghrelin, a hormone, is increasingly recognized for its role in mood regulation and depression.
  • The specific antidepressant-like effects of ghrelin in the context of ovariectomized mice, a model for postmenopausal depression, remain largely unexplored.

Purpose of the Study:

  • To investigate the potential antidepressant-like effects of ghrelin administration in ovariectomized mice.
  • To elucidate the underlying mechanisms, including the involvement of estrogen receptors and key neurotrophic factors.

Main Methods:

  • Ovariectomized mice were treated with ghrelin, and their behavior was assessed using the forced swim test.
  • Immunohistochemistry was employed to evaluate c-Fos expression, while western blotting analyzed brain-derived neurotrophic factor (BDNF) and phosphorylated cAMP response element-binding protein (pCREB)/CREB levels.
  • Bromodeoxyuridine (BrdU) expression was measured to assess cell proliferation.

Main Results:

  • Ghrelin significantly reduced immobility time in the forced swim test, indicating antidepressant-like activity.
  • Tamoxifen, an estrogen antagonist, reversed the effects of ghrelin on immobility and c-Fos expression.
  • Ghrelin treatment increased hippocampal BDNF levels and BrdU expression, suggesting neuroprotective and neurogenic effects.

Conclusions:

  • Ghrelin exhibits significant antidepressant-like effects in ovariectomized mice.
  • The involvement of estrogen receptors is implicated in mediating ghrelin's antidepressant actions.
  • Ghrelin may represent a potential therapeutic agent for depression, particularly in conditions associated with estrogen deficiency.